newsfilter
← Latest News
GlobeNewswire·

Albireo to Report Q2 2022 Financial Results on August 15, 2022

BOSTON, Aug. 01, 2022 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (NASDAQ:ALBO), a rare liver disease company developing novel bile acid modulators, today announced that management will host a conference call and live audio webcast at 4:30 p.m. ET on Au